Derivation of Mac-1+Gr-1+splenocytes on D+7 after transplantation
. | Graft composition without G-CSF . | Graft composition with G-CSF . | ||
---|---|---|---|---|
HSCs, n = 10 . | HSC + CMP/GMP, n = 5 . | HSCs, n = 7 . | HSC + CMP/GMP, n = 6 . | |
Total splenocytes | 111.1 ± 12.9 | 181.5 ± 12.9* | 63.4 ± 7.5 | 300.8 ± 40.0*,† |
Total CD45+splenocytes | 82.7 ± 14.0 | 105.0 ± 26.2 | 43.1 ± 7.5 | 142.0 ± 20.6*,† |
Total Mac-1+Gr-1+ | 13.3 (16%) | 29.8 (28%)* | 3.7 (8.6%) | 29.5 (21%)*,† |
Derivation | ||||
Donor HSCs | 11.6 ± 4.2 | 4.7 ± 1.2 | 2.5 ± 0.7 | 6.4 ± 1.4† |
Donor CMP/GMP | — | 20.1 ± 4.9 | — | 14.9 ± 1.8 |
Host | 1.6 ± 0.3 | 5.0 ± 1.6 | 1.2 ± 0.5 | 8.2 ± 5.5† |
. | Graft composition without G-CSF . | Graft composition with G-CSF . | ||
---|---|---|---|---|
HSCs, n = 10 . | HSC + CMP/GMP, n = 5 . | HSCs, n = 7 . | HSC + CMP/GMP, n = 6 . | |
Total splenocytes | 111.1 ± 12.9 | 181.5 ± 12.9* | 63.4 ± 7.5 | 300.8 ± 40.0*,† |
Total CD45+splenocytes | 82.7 ± 14.0 | 105.0 ± 26.2 | 43.1 ± 7.5 | 142.0 ± 20.6*,† |
Total Mac-1+Gr-1+ | 13.3 (16%) | 29.8 (28%)* | 3.7 (8.6%) | 29.5 (21%)*,† |
Derivation | ||||
Donor HSCs | 11.6 ± 4.2 | 4.7 ± 1.2 | 2.5 ± 0.7 | 6.4 ± 1.4† |
Donor CMP/GMP | — | 20.1 ± 4.9 | — | 14.9 ± 1.8 |
Host | 1.6 ± 0.3 | 5.0 ± 1.6 | 1.2 ± 0.5 | 8.2 ± 5.5† |